[Update on the pharmacological treatment of unstable angina.]
(1996) Archives des Maladies du Coeur et des Vaisseaux — Vol. 89, p. 15-18 (1996)
Files
No attached file found for this publication.
Details
- Authors
- Abstract
- The combined death/infarct rate in the weeks following unstable angina ranges from 10 to 40 %. Aspirin and GP Ilb/IIIa antagonists reduce the mortality and morbidity, which has not been demonstrated with heparin. The short term clinical results of treatment with hirudin are better than those with heparin. A rebound biological effect after heparin or hirudin therapy may have adverse clinical consequences. Nitrate derivatives have a role to play and adjuvant therapy includes the betablockers and some calcium antagonists in special indications.
- Affiliations
Citations
Col, J. (1996). [Update on the pharmacological treatment of unstable angina.]. Archives des Maladies du Coeur et des Vaisseaux, 89, 15-18. https://hdl.handle.net/2078.5/143645 (Original work published 1996)